ANALYSIS OF PHARMACEUTICAL PRODUCTS EXPORTS FROM RUSSIAN FEDERATION

Export of goods, including medicines and medical devices, is desirable for the economic development of every country. The aim of the study is to examine the state, structure and development trends of Russian pharmaceutical exports. The study materials were data from the United Nations (UN) trade database for the period 2019-2023. The methods of content analysis, time series analysis, analysis, synthesis and generalization of information were used. To assess the possibility of expanding the geographic presence of Russian pharmaceutical products, data on exports to countries within the Eurasian Economic Union (EAEU) were excluded from the study. It was revealed that the share of pharmaceutical exports to countries outside the EAEU varies significantly in the study period: from 64% in 2021 to 45% in 2022. There was a decrease in the number of countries to which goods of group 30 "Pharmaceutical products" are exported from the Russian Federation, from 119 countries in 2019 to 91 in 2023. As of 2023, the leading countries purchasing domestic pharmaceutical products were: Uzbekistan, Azerbaijan, Turkey, Nicaragua, Slovenia, the Republic of Moldova, Georgia, Uganda, Finland, Morocco. During the study period, the volume of exports of domestic goods increased by 35.2% (in monetary terms). It should be noted that the sales volumes of the vaccine segment increased multiple times in 2021. The bulk of exports of group 30 goods are medicines consisting of mixed or unmixed products - 61.4%; human blood, animal blood, immune serums - 35.4%. The study showed the possibility of expanding the geographic presence of the Russian pharmaceutical industry, possibly through the countries of Latin America, Southeast Asia and the Middle East.